We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$19.4B
AUM Growth
+$1.45B
Cap. Flow
+$1.27B
Cap. Flow %
6.57%
Top 10 Hldgs %
32.14%
Holding
3,720
New
1,674
Increased
652
Reduced
743
Closed
445

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$182M
2
KCG
KCG Holdings, Inc.
KCG
+$85.1M
3
EBAY icon
eBay
EBAY
+$78.6M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$71.1M
5
AGN
Allergan plc
AGN
+$64.1M

Sector Composition

Rank Sector Weight
1 Healthcare 2.37%
2 Consumer Discretionary 1.84%
3 Technology 1.55%
4 Energy 1.37%
5 Industrials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
3001
Supernus Pharmaceuticals
SUPN
$2.68B
$3K ﹤0.01%
162
-34,828
-100% -$496K
TCRT icon
3002
Alaunos Therapeutics
TCRT
$4.74M
$3K ﹤0.01%
+2
New +$3.1K
TOWN icon
3003
Towne Bank
TOWN
$3.35B
$3K ﹤0.01%
+176
New +$2.86K
CMRX
3004
DELISTED
Chimerix, Inc.
CMRX
$3K ﹤0.01%
+64
New +$2.56K
TWOU
3005
DELISTED
2U Inc
TWOU
$3K ﹤0.01%
+3
New +$2.49K
CHS
3006
DELISTED
Chicos FAS, Inc.
CHS
$3K ﹤0.01%
+200
New +$3.41K
INFI
3007
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$3K ﹤0.01%
+268
New +$3.44K
ACOR
3008
DELISTED
Acorda Therapeutics
ACOR
$3K ﹤0.01%
+1
New +$3.86K
BNFT
3009
DELISTED
Benefitfocus, Inc.
BNFT
$3K ﹤0.01%
+68
New +$2.56K
XLRN
3010
DELISTED
Acceleron Pharma
XLRN
$3K ﹤0.01%
88
-8,925
-99% -$288K
STML
3011
DELISTED
Stemline Therapeutics, Inc.
STML
$3K ﹤0.01%
+265
New +$3.68K
OLBK
3012
DELISTED
Old Line Bancshares, Inc.
OLBK
$3K ﹤0.01%
+183
New +$2.92K
HF
3013
DELISTED
HFF Inc.
HF
$3K ﹤0.01%
+79
New +$3.19K
GOV
3014
DELISTED
Government Properties Income Trust
GOV
$3K ﹤0.01%
+173
New +$3.53K
PNK
3015
DELISTED
Pinnacle Entertainment Inc.
PNK
$3K ﹤0.01%
68
AVHI
3016
DELISTED
A V Homes, Inc.
AVHI
$3K ﹤0.01%
+176
New +$2.74K
STRP
3017
DELISTED
Straight Path Communications Inc.
STRP
$3K ﹤0.01%
+79
New +$1.92K
CBR
3018
DELISTED
CIBER Inc.
CBR
$3K ﹤0.01%
+798
New +$2.9K
SKUL
3019
DELISTED
SKULLCANDY INC
SKUL
$3K ﹤0.01%
+445
New +$4.06K
RLYP
3020
DELISTED
RELYPSA INC COM
RLYP
$3K ﹤0.01%
+76
New +$2.61K
RCAP
3021
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
$3K ﹤0.01%
+430
New +$3.49K
WX
3022
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$3K ﹤0.01%
+68
New +$2.87K
HNH
3023
DELISTED
Handy & Harman Holdings Ltd.
HNH
$3K ﹤0.01%
+88
New +$3.14K
MCUR
3024
DELISTED
Macrocure Ltd.
MCUR
$3K ﹤0.01%
+200
New +$2.23K
HAWK
3025
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$3K ﹤0.01%
79
-183,269
-100% -$6.83M

Similar funds

Jefferies Group's Q2 2015 Portfolio in Review

As of Q2 2015, Jefferies Group held 3,720 positions worth $19.4B, up 8.1% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jefferies Group deployed $1.27B of net new capital in Q2 2015, opening 1,674 new positions and adding to 652 existing holdings. Its largest new stake was El Pollo Loco: 3,675,000 shares worth $76.1M.

By sector, the portfolio is most concentrated in Healthcare at 2.4% of assets, down from 3.8% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Viatris, an estimated $182M trimmed.

  • Jefferies Group's largest Q2 2015 buy was El Pollo Loco: 3,675,000 shares worth $76.1M.
  • Jefferies Group added most to iShares Russell 2000 ETF in Q2 2015, an estimated $219M increase.
  • Jefferies Group's biggest Q2 2015 reduction was Viatris, cutting an estimated $182M.
  • Jefferies Group fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $26.4M.
  • Jefferies Group's ten largest holdings make up 32% of its $19.4B portfolio in Q2 2015.
  • Jefferies Group opened 1,674 new positions and closed 445 in Q2 2015.
  • Jefferies Group's portfolio value rose 8.1% quarter-over-quarter to $19.4B.

Based on Jefferies Group's 13F filing for Q2 2015, filed 18 Aug 2015.